AFL:NYE-Aflac Incorporated (USD)

COMMON STOCK | Insurance-Life | NYE

Last Closing Price

USD 53.37

Change

0.00 (0.00)%

Market Cap

USD 36.27B

Volume

2.17M

Avg Analyst Target

USD 53.21 (-0.29%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical care, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia. Address: 1932 Wynnton Road, Columbus, GA, United States, 31999

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-25 )

Largest Industry Peers for Insurance-Life

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LFC China Life Insurance Company L..

N/A

USD113.37B 5.14 N/A
MET-PA MetLife, Inc

N/A

USD50.62B 21.26 N/A
MET MetLife, Inc

N/A

USD50.45B 47.01 N/A
PUK Prudential plc

N/A

USD49.24B 23.07 N/A
MET-PE MetLife, Inc

N/A

USD49.20B 4.12 N/A
PRU Prudential Financial, Inc

N/A

USD39.20B 14.79 N/A
MFC Manulife Financial Corporation

N/A

USD37.05B 8.96 N/A
LNC Lincoln National Corporation

N/A

USD11.48B 17.29 N/A
GL Globe Life Inc

N/A

USD9.62B 12.76 N/A
PRI Primerica, Inc

N/A

USD5.73B 14.09 N/A

ETFs Containing AFL

Symbol Name Weight Mer Price(Change) Market Cap
CORP PIMCO Investment Grade Co.. 0.00 % 0.20 %

N/A

USD0.79B
CWS AdvisorShares Focused Equ.. 0.00 % 0.77 %

N/A

USD0.03B
FHF:CA First Trust Nasdaq Clean .. 0.00 % 0.79 %

N/A

USD0.01B
FLI:CA CI U.S. & Canada Lifeco I.. 0.00 % 0.93 %

N/A

USD0.11B
IAK iShares U.S. Insurance ET.. 0.00 % 0.42 %

N/A

USD0.10B
IWS iShares Russell Mid-Cap V.. 0.00 % 0.24 %

N/A

USD14.20B
JKI iShares Morningstar Mid-C.. 0.00 % 0.06 %

N/A

USD0.41B
VLIQ:XETRA Vanguard Global Liquidity.. 0.00 % 0.00 %

N/A

USD0.01B

Market Performance

  Market Performance vs.
Industry/Classification (Insurance-Life)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.01% 88% B+ 73% C
Dividend Return 1.48% 43% F 47% F
Total Return 21.50% 76% C 73% C
Trailing 12 Months  
Capital Gain 45.15% 71% C- 69% D+
Dividend Return 3.32% 50% F 51% F
Total Return 48.46% 71% C- 70% C-
Trailing 5 Years  
Capital Gain 44.85% 79% C+ 62% D-
Dividend Return 13.48% 42% F 48% F
Total Return 58.33% 64% D 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.62% 76% C 62% D-
Dividend Return 2.28% 50% F 53% F
Total Return 10.90% 76% C 62% D-
Risk Return Profile  
Volatility (Standard Deviation) 24.23% 65% D 46% F
Risk Adjusted Return 44.98% 82% B- 55% F
Market Capitalization 36.27B 63% D 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Insurance-Life)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 6.86 71% C- 86% B
Price/Book Ratio 1.13 33% F 70% C-
Price / Cash Flow Ratio 6.09 50% F 59% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 18.82% 94% A 80% B-
Return on Invested Capital 1.86% 29% F 38% F
Return on Assets 2.14% 88% B+ 49% F
Debt to Equity Ratio 23.54% 53% F 79% C+
Technical Ratios  
Short Ratio 4.08 25% F 21% F
Short Percent 2.05% 40% F 60% D-
Beta 0.99 82% B- 57% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.